MATINAS BIOPHARMA HOLDINGS, INC. Increase (Decrease) in Accounts Receivable
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Increase (Decrease) in Accounts Receivable of $89.81 thousand for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2018-11-09
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in accounts receivable for the quarter ending 2017-09-30 was -$5.00.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in accounts receivable for the quarter ending 2015-03-31 was -$15.54K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in accounts receivable for the quarter ending 2014-03-31 was $0.00.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month |
|---|---|---|---|
| 2018-06-30 | $89.81K 10-Q · filed 2018-08-09 | ||
| 2017-09-30 | -$5.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$5.08K 10-Q · filed 2018-11-09 | |
| 2017-06-30 | -$5.08K 10-Q · filed 2018-08-09 | ||
| 2015-03-31 | -$15.54K 10-Q · filed 2015-05-15 | ||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |